Shrikant Anant

20PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 25, 2024
Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer.

David Standing, Prasad Dandawate, Sumedha Gunewardena

|Apr 22, 2024
DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma.

Levi Arnold, Marion Yap, Laura Jackson

|Nov 29, 2023
Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression.

Levi Arnold, Juan Pineda Gomez, Michael Barry

|May 13, 2023
The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy.

David Standing, Emma Feess, Satvik Kodiyalam

|Apr 13, 2023
Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer.

Sangita Bhattacharyya, Hindole Ghosh, Obdulia Covarrubias-Zambrano

|Sep 09, 2022
Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin.

Mohamed Alalem, Mrinalini Bhosale, Atul Ranjan

Pageof 4

Frequent Collaborators

6 joint publications

Roy A Jensen

4 joint publications

Scott J Weir

2 joint publications

Dharmalingam Subramaniam

2 joint publications

Sufi Mary Thomas